StableEyes With Active Neurofeedback

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
Johns Hopkins University
Study ID
NCT05622344
Status
Recruiting
Apply to this trial

Conditions

  • Motion Sickness
  • Space Motion Sickness
  • Vestibular Disorder
  • Vestibular Schwannoma

Eligibility Criteria

Sex
ALL
Age
21 Years - 70 Years
Healthy Volunteers
Accepted

Interventions

  • Traditional Therapy — BEHAVIORAL
    Exercises that teaches subjects to move their heads while viewing still or moving targets.
  • SWAN — DEVICE
    The SWAN device uses video-oculography to monitor head motion while guiding participants to move their head in yaw, pitch, roll planes for 15 minutes. Feedback is provided regarding frequency and plane of head rotation

Study Details

The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness and enhance postural recovery following centrifugation or unilateral vestibular nerve deafferentation surgery.

Key Dates

Start date
Aug 8, 2022
Status verified
Nov 2025
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
48 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Traditional Vestibular Physical Therapy (VPT) JHU
    Subjects that have had their eighth cranial nerve resected will receive traditional vestibular rehabilitation exercises at Johns Hopkins University (JHU) site.
  • Experimental: SWAN VPT JHU
    Subjects that have had their eighth cranial nerve resected will receive the automated vestibular rehabilitation method
  • Experimental: SWAN Motion Sick Dayton
    Healthy control subjects that meet similar similar physical characteristics of astronauts will receive the automated vestibular rehabilitation method post motion sickness.
  • No Intervention: Traditional Motion Sick Dayton
    Typically, the suggestion for treating motion sickness once it has started is to avoid motion. Therefore, healthy control subjects that meet similar similar physical characteristics of astronauts will not receive any post motion sickness treatment.

Primary Outcome Measure

Change in Motion sickness intensity as assessed by subjective rating [ Time Frame: Daily for up to 4 weeks ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Johns Hopkins UniversityBaltimoreMaryland21287
Michael C Schubert, PhD
[email protected]
410-955-3403
Colin R Grove, PhD (SUB_INVESTIGATOR)
Naval Medical Research UnitDaytonOhio45433-

Find similar trials in Baltimore, MD

By research site
Johns Hopkins University· Baltimore, MDNaval Medical Research Unit· Dayton, OH

Related Studies